Molecular design of a high-performance polymeric carrier for delivery of a variety of boronic acid-containing drugs

Design and discovery of boronic acid drugs

(2020) Jessica Plescia et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Bortezomib-Responsive Refractory Anti-N-Methyl-d-Aspartate Receptor Encephalitis

(2019) Ramona Cordani et al.   PEDIATRIC NEUROLOGY

Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma

(2018) Zhaoxin Gu et al.   Acta Biomaterialia

Micellar nanoformulation of lipophilized bortezomib: high drug loading, improved tolerability and targeted treatment of triple negative breast cancer

(2017) Kaiqi Wu et al.   Journal of Materials Chemistry B

Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: anin vitrostudy on human pancreatic cancer cells and adenocarcinoma human lung alveolar basal epithelial cells

(2016) Sílvia Castro Coelho et al.   Expert Opinion on Drug Delivery

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

(2016) Amy S. Paller et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy

(2015) Song Shen et al.   JOURNAL OF CONTROLLED RELEASE

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma

(2015) Guendalina Zuccari et al.   JOURNAL OF CONTROLLED RELEASE

Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols

(2015) Stephen J. Glynn et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Nanocarrier for Poorly Water-Soluble Anticancer Drugs—Barriers of Translation and Solutions

(2014) Mayuri Narvekar et al.   AAPS PHARMSCITECH

Bortezomib for Refractory Autoimmunity in Pediatrics

(2014) Pooja Khandelwal et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

(2014) Q. Dou et al.   CURRENT CANCER DRUG TARGETS

Tavaborole: First Global Approval

(2014) Anthony Markham   DRUGS

An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma

(2014) Massimo Offidani et al.   OncoTargets and Therapy

The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy

(2013) Jia Shen et al.   BIOMATERIALS

Acidic extracellular microenvironment and cancer

(2013) Yasumasa Kato et al.   Cancer Cell International

The Protection and Therapy Effects of Bortezomib in Murine Acute Graft-Versus-Host Disease

(2013) Z. Li et al.   TRANSPLANTATION PROCEEDINGS

Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation

(2012) Anjali Mishra et al.   CANCER CELL

Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis

(2012) Issei Saeki et al.   JOURNAL OF GASTROENTEROLOGY

Phase I Trial of Induction Histone Deacetylase and Proteasome Inhibition Followed by Surgery in Non–Small-Cell Lung Cancer

(2012) David R. Jones et al.   Journal of Thoracic Oncology

pH-Responsive Drug Delivery by Amphiphilic Copolymer through Boronate-Catechol Complexation

(2012) Suhong Wu et al.   ChemPlusChem

In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells

(2011) Dharminder Chauhan et al.   CLINICAL CANCER RESEARCH

Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry

(2011) Minoru Ishikawa et al.   JOURNAL OF MEDICINAL CHEMISTRY

Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer Cells

(2011) Jing Su et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Biomedical applications of boronic acid polymers

(2011) Jennifer N. Cambre et al.   POLYMER

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

(2010) Jun Fang et al.   ADVANCED DRUG DELIVERY REVIEWS

Fluorescence Spectroscopy: An Emerging Excellent Diagnostic Tool in Medical Sciences

(2010) Aamir Shahzad et al.   APPLIED SPECTROSCOPY REVIEWS

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

(2010) S. Bringhen et al.   BLOOD

Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer

(2010) E. Kupperman et al.   CANCER RESEARCH

Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation

(2010) H. M. H. G. Albers et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase

(2009) Rachel A. Powers et al.   PROTEIN SCIENCE

Bortezomib attenuates murine collagen-induced arthritis

(2008) S-W Lee et al.   ANNALS OF THE RHEUMATIC DISEASES

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

(2008) H. Maeda et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Diffusion Coefficients of Several Rhodamine Derivatives as Determined by Pulsed Field Gradient–Nuclear Magnetic Resonance and Fluorescence Correlation Spectroscopy

(2008) P.-O. Gendron et al.   JOURNAL OF FLUORESCENCE

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)

(2008) Roger Henriksson et al.   RADIOTHERAPY AND ONCOLOGY